Q2 2024 · 13F-HR
SILVERARC CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2024-08-14 · accession 0001420506-24-001528
$423.9M
Reported value
70
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N5749R100 | 2GH | MERUS N V | $36.9M | 8.71% | 623,628 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $35.3M | 8.33% | 465,710 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $21.1M | 4.99% | 517,734 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $18.5M | 4.36% | 1,102,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $18.4M | 4.35% | 7,816,926 | Common | SOLE |
| 457669907 | — | INSMED INC | $16.8M | 3.95% | 250,000 | CALL | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $16.6M | 3.91% | 486,306 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $14.7M | 3.46% | 625,087 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $13.9M | 3.27% | 374,910 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $13.2M | 3.11% | 192,345 | Common | SOLE |
| 73730P108 | PSTXUSD | POSEIDA THERAPEUTICS INC | $10.5M | 2.49% | 3,607,999 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $10.2M | 2.40% | 1,206,214 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $9.4M | 2.21% | 140,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $8.7M | 2.06% | 36,000 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $8.0M | 1.88% | 1,603,580 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $7.8M | 1.84% | 172,492 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $7.6M | 1.79% | 1,075,812 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $7.6M | 1.79% | 370,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $7.6M | 1.79% | 184,662 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $6.7M | 1.57% | 1,442,841 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $6.6M | 1.57% | 42,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $6.6M | 1.56% | 560,883 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $6.1M | 1.44% | 282,248 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $6.0M | 1.42% | 455,800 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $5.9M | 1.40% | 546,863 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $5.6M | 1.32% | 1,768,770 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $5.1M | 1.21% | 500,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $5.0M | 1.19% | 2,500,585 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $5.0M | 1.17% | 5,500,000 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $4.7M | 1.11% | 1,000,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $4.6M | 1.08% | 101,187 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $4.5M | 1.06% | 19,365 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $4.4M | 1.04% | 304,633 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $4.2M | 1.00% | 999,270 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $3.5M | 0.82% | 100,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $3.3M | 0.78% | 122,849 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $2.8M | 0.66% | 67,296 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $2.8M | 0.65% | 70,516 | Common | SOLE |
| 09075X108 | — | BIODESIX INC | $2.8M | 0.65% | 1,808,959 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $2.7M | 0.64% | 79,194 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $2.7M | 0.63% | 472,995 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.6M | 0.61% | 260,009 | Common | SOLE |
| 157085101 | CERS | CERUS CORP | $2.6M | 0.61% | 1,465,744 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $2.5M | 0.59% | 1,501,113 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $2.5M | 0.59% | 844,235 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $2.5M | 0.59% | 1,062,062 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $2.5M | 0.59% | 109,892 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $2.5M | 0.59% | 263,841 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $2.5M | 0.58% | 495,471 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $2.5M | 0.58% | 398,436 | Common | SOLE |
| M4119S104 | — | EVOGENE LTD | $2.0M | 0.47% | 3,079,739 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $1.9M | 0.45% | 141,518 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $1.6M | 0.37% | 370,000 | Common | SOLE |
| 60785L207 | — | MODULAR MED INC | $1.4M | 0.34% | 900,000 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $1.1M | 0.27% | 328,504 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $1.1M | 0.26% | 40,000 | Common | SOLE |
| 00166B955 | — | ALX ONCOLOGY HLDGS INC | $1.0M | 0.24% | 167,900 | PUT | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $920,772 | 0.22% | 467,397 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $870,000 | 0.21% | 100,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $739,307 | 0.17% | 92,298 | Common | SOLE |
| 608550208 | MTEMEUR | MOLECULAR TEMPLATES INC | $717,414 | 0.17% | 623,838 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $711,664 | 0.17% | 166,666 | Common | SOLE |
| 12529R907 | — | C4 THERAPEUTICS INC | $693,000 | 0.16% | 150,000 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $612,000 | 0.14% | 15,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $484,525 | 0.11% | 558,466 | Common | SOLE |
| 59045L906 | — | MERSANA THERAPEUTICS INC | $338,283 | 0.08% | 168,300 | CALL | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $298,137 | 0.07% | 99,379 | Common | SOLE |
| 01626L105 | — | ALIGOS THERAPEUTICS INC | $229,430 | 0.05% | 655,515 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $188,775 | 0.04% | 2,500 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $6,363 | 0.00% | 104,828 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.